The deal, which features up to $385 million in milestones, gives Biogen exclusive rights to commercialize Stoke’s ...

Former Stoke City players have paid tribute to club legend George Eastham at a memorial service to celebrate his ...

The school leaders taking unprecedented action to ensure a safe learning environment with amenities in good working order ...

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

Biogen and Stoke partner on zorevunersen for Dravet syndrome, with a Phase 3 trial starting in 2025. Stoke gets $165 million ...

Four fire engines are currently at the scene of a blaze on a Stoke-on-Trent estate. Fire has been seen pouring from the roof ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

Norwich City will look to keep their play-off hopes alive when they welcome Stoke City to Carrow Road on Saturday afternoon ...

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...

Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...

When you buy through links on our articles, Future and its syndication partners may earn a commission.